Yearly Publication Trends - immunogenicity

Year	Publication Count
2024	2391
2023	4513
2022	2873
2021	2108
2020	1474
2019	1017
2018	669
2017	689
2016	647
2015	604
2014	646

Relevant Publications

Split intein-mediated backbone cyclization enhances the stability and activity of staphylokinase, a potent fibrin-selective plasminogen activator.

Issue Release: 2024

Cancer treatment with biosimilar drugs: A review.

Issue Release: 2024

Delivery of CRISPR/Cas9 system by AAV as vectors for gene therapy.

Issue Release: 2024

First-in-human clinical trial results with ABBV-184, a first-in-class T-cell Receptor/Anti-CD3 bispecific protein, in adults with Previously treated AML or NSCLC.

Issue Release: 2024

T. gondii excretory proteins promote the osteogenic differentiation of human bone mesenchymal stem cells via the BMP/Smad signaling pathway.

Issue Release: 2024

Steering the course of CAR T cell therapy with lipid nanoparticles.

Issue Release: 2024

COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies.

Issue Release: 2024

Whole-eye transplantation: Current challenges and future perspectives.

Issue Release: 2024

Serotype-Specific Epidemiological Patterns of Inapparent versus Symptomatic Primary Dengue Virus Infections: A 17-year cohort study in Nicaragua.

Issue Release: 2024

New insights into red blood cells in tumor precision diagnosis and treatment.

Issue Release: 2024

Dual depletion of myeloid-derived suppressor cells and tumor cells with self-assembled gemcitabine-celecoxib nano-twin drug for cancer chemoimmunotherapy.

Issue Release: 2024

Exploring the potential of cell-derived vesicles for transient delivery of gene editing payloads.

Issue Release: 2024

Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity.

Issue Release: 2024

MIL-53(Al)-oil/water emulsion composite as an adjuvant promotes immune responses to an inactivated pseudorabies virus vaccine in mice and pigs.

Issue Release: 2024

Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting.

Issue Release: 2024

Expression and Prognostic Significance of LAG-3, TIGIT, VISTA, and IDO1 in Endometrial Serous Carcinoma.

Issue Release: 2024

Correction to: Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies.

Issue Release: 2024

Sustained release system from PLGA particles co-encapsulated with inactivated influenza virus with natural killer T cell agonist α-galactosylceramide.

Issue Release: 2024

The function and application of edible fungal polysaccharides.

Issue Release: 2024

Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production.

Issue Release: 2024

What is Incidence Rate?

Who Can Benefit from CISA Services?

Why are SIAs Needed?

How does the CDC support global vaccination efforts?

What is Genetic Variability?

How Do Vaccines Influence Outbreak Investigations?

What Role Do International Organizations Play?

What is Measles?

What is the Role of Helper T Cells in Vaccination?

Where Can Patients and Parents Find More Information?

Partnered Content Networks

Relevant Topics